Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

4,277 studies for “Alzheimer disease”

Evaluation of a Decision-Support Tool for Blood Biomarker Testing for Alzheimer's Disease in Primary CareNot Yet Recruiting
NCT07812337NAUpdated Sep 10, 2026
Sponsor: University of Wisconsin, Madison
Cognitive Abnormality
United States
PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI)Recruiting
NCT07169630Phase 1Updated Sep 10, 2026
Sponsor: National Institute of Mental Health (NIMH)
Alzheimer s Disease · Mild Cognitive Impairment · Healthy
United States
A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's DiseaseRecruiting
NCT07717411Phase 3Updated Sep 10, 2026
Sponsor: Hoffmann-La Roche
Alzheimer's Disease
United States, Canada, China, United Kingdom
Multimodal Biomarkers in Individual With Cognitive Impairment and DementiaNot Yet Recruiting
NCT07812480N/AUpdated Sep 10, 2026
Sponsor: Assiut University
Dementia Disorders · Mild Cognitive Impairment (MCI)
Amyloid PET Imaging in the Baltimore Longitudinal Study of AgingRecruiting
NCT07099053N/AUpdated Sep 10, 2026
Sponsor: National Institute on Aging (NIA)
Aging
United States
Aging Brain Care Virtual ProgramCompleted
NCT06245499NAUpdated Sep 10, 2026
Sponsor: Indiana University
Dementia · Alzheimer Disease
United States
Study of Repetitive Behaviors in Alzheimer's DiseaseRecruiting
NCT07732842N/AUpdated Sep 10, 2026
Sponsor: Centre Hospitalier Esquirol
Alzheimer Disease · Anterograde Amnesia · Anosognosia
France
InRAD Observational StudyRecruiting
NCT07213700N/AUpdated Sep 10, 2026
Sponsor: Stichting International Registry for Alzheimer's Disease and other Dementias Foundation
Alzheimer's Disease(AD) · Mild Cognitive Impairment (MCI) · Subjective Cognitive Decline (SCD) · Non-Alzheimer Degenerative Dementia
Austria, Belgium, Brazil, Czechia, Greece +8 more
Digitally-enhanced, Decentralized, Multi-omics Observational CohortEnrolling By Invitation
NCT04701177N/AUpdated Sep 10, 2026
Sponsor: Greece 2021 Committee
Presymptomatic Disease · Mild Cognitive Impairment · Memory Loss (Excluding Dementia) · Cognitive Change
Greece, Spain
The Ketogenic Diet for Alzheimer's DiseaseTerminated
NCT04701957NAUpdated Sep 10, 2026
Sponsor: Assistance Publique - Hôpitaux de Paris
Alzheimer Disease, Early Onset
France
A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (HOPE Study)Completed
NCT05637801NAUpdated Sep 9, 2026
Sponsor: Cognito Therapeutics, Inc.
Alzheimer Disease · Alzheimer Disease 1 · Alzheimer Disease 2 · Alzheimer Disease 3
United States
Effect of Hydralazine on Alzheimer's DiseaseCompleted
NCT04842552Phase 3Updated Sep 9, 2026
Sponsor: Shahid Sadoughi University of Medical Sciences and Health Services
Alzheimer Disease
Iran
Piromelatine 20 mg in Participants With Mild Dementia Due to Alzheimer's DiseaseTerminated
NCT05267535Phase 2, Phase 3Updated Sep 9, 2026
Sponsor: Neurim Pharmaceuticals Ltd.
Alzheimer's Disease
United States, Canada
A Trial to Evaluate the Safety and Efficacy of Benfotiamine in Patients With Early Alzheimer's Disease (BenfoTeam)Active Not Recruiting
NCT06223360Phase 2Updated Sep 9, 2026
Sponsor: Weill Medical College of Cornell University
Alzheimer Disease
United States
Glutathione, Brain Metabolism and Inflammation in Alzheimer's DiseaseActive Not Recruiting
NCT04740580EARLY_Phase 1Updated Sep 9, 2026
Sponsor: Baylor College of Medicine
Alzheimer Disease
United States
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7812653 in Participants With Early Symptomatic Alzheimer's Disease (eAD)Active Not Recruiting
NCT07234942Phase 1Updated Sep 9, 2026
Sponsor: Hoffmann-La Roche
Alzheimer's Disease
Canada, Netherlands, Spain, Sweden, United Kingdom
REVERSE-Long COVID-19 With Baricitinib StudyWithdrawn
NCT05858515Phase 3Updated Sep 9, 2026
Sponsor: Vanderbilt University Medical Center
Post-Acute COVID-19 Syndrome
United States
A Study of Psychedelics in Healthy Older Adults With Low Well-beingRecruiting
NCT07386730Phase 1Updated Sep 9, 2026
Sponsor: Jennifer Mitchell
Anhedonia in Healthy Volunteers · Older Adults (50-90 Years)
United States
Inherited Diseases, Caregiving, and Social NetworksCompleted
NCT01498263N/AUpdated Sep 9, 2026
Sponsor: National Human Genome Research Institute (NHGRI)
Undiagnosed Disease · Healthy Volunteer (Adult With Typically Developing Child) · Inherited Neurodegenerative Disorders · Inherited Metabolic Disorders (Inborn Errors of Metabolism)
United States
The Wandering Nerve: Gateway to Boost Alzheimer's Disease Related Cognitive PerformanceCompleted
NCT04908358NAUpdated Sep 9, 2026
Sponsor: Massachusetts General Hospital
Aging
United States
Cerebrospinal Fluid Mitochondrial Biomarkers in Ischemic Stroke and Alzheimer DiseaseCompleted
NCT07600996N/AUpdated Sep 9, 2026
Sponsor: Capital Medical University
Ischemic Stroke · Alzheimer Disease (AD)
China
Exploring the Utility of [18F]3F4AP for Demyelination ImagingRecruiting
NCT06999434Phase 1Updated Sep 9, 2026
Sponsor: Yale University
Demyelinating Disorders · MCI · Alzheimer's Disease (AD) · MS (Multiple Sclerosis)
United States
Alzheimer's Tau Platform: Regimen A - AADvac1Enrolling By Invitation
NCT07167966Phase 2Updated Sep 8, 2026
Sponsor: Paul S. Aisen
Preclinical Alzheimer's Disease · Prodromal Alzheimer's Disease · Alzheimer Disease
United States
Alzheimer's Disease Genetics StudyRecruiting
NCT00064870N/AUpdated Sep 8, 2026
Sponsor: Indiana University
Alzheimer Disease · Late Onset Alzheimer Disease · Dementia
United States
Head-to-Head Harmonization of Tau Tracers in Alzheimer's DiseaseActive Not Recruiting
NCT05361382Phase 1Updated Sep 8, 2026
Sponsor: Tharick Pascoal
Alzheimer Disease
United States, Canada, Spain

4,277 studies found